Profiel
Benjamin Perry is the founder of MPC Therapeutics SA, holding the title of Director since 2018.
Dr. Perry is a Venture Partner at Medicxi Ventures (Jersey) Ltd. since 2022.
Education includes a doctorate from Imperial College London, conferred in 2002, and a graduate degree from Swansea University, conferred in 1999.
Actieve functies van Benjamin Perry
| Bedrijven | Functie | Begin |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Private Equity Investor | 01-11-2022 |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology Develops small molecules which modulate mitochondrial functions | Oprichter | 01-01-2018 |
Opleiding van Benjamin Perry
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swansea University
Swansea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Finance |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology Develops small molecules which modulate mitochondrial functions | Health Technology |
















